Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Promyelocytic Leukemia (PML) gene regulation: implication towards curbing oncogenesis.

Datta N, Islam S, Chatterjee U, Chatterjee S, Panda CK, Ghosh MK.

Cell Death Dis. 2019 Sep 10;10(9):656. doi: 10.1038/s41419-019-1889-2.

2.

Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.

Das N, Datta N, Chatterjee U, Ghosh MK.

Cell Signal. 2016 Jun;28(6):675-87. doi: 10.1016/j.cellsig.2016.03.007. Epub 2016 Mar 21.

PMID:
27012497
3.
4.

Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer.

Chatterjee A, Chatterjee U, Ghosh MK.

Cell Death Dis. 2013 Mar 14;4:e543. doi: 10.1038/cddis.2013.63.

5.

Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression.

Xu ZX, Zhao RX, Ding T, Tran TT, Zhang W, Pandolfi PP, Chang KS.

J Biol Chem. 2004 Jan 16;279(3):1838-44. Epub 2003 Nov 3.

6.

Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.

Li W, Jia M, Qin X, Hu J, Zhang X, Zhou G.

FEBS J. 2013 Dec;280(23):6128-40. doi: 10.1111/febs.12533. Epub 2013 Oct 8.

7.
8.

Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.

Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.

Mol Endocrinol. 2006 Dec;20(12):3070-82. Epub 2006 Aug 10.

PMID:
16901971
9.

Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.

Duan R, Ginsburg E, Vonderhaar BK.

Mol Cell Endocrinol. 2008 Jan 16;281(1-2):9-18. Epub 2007 Oct 13.

PMID:
18022314
10.

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

Bièche I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R.

Oncogene. 2001 Dec 6;20(56):8109-15.

11.

Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP.

J Natl Cancer Inst. 2004 Feb 18;96(4):269-79.

PMID:
14970276
12.

Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.

Cho MA, Lee MK, Nam KH, Chung WY, Park CS, Lee JH, Noh T, Yang WI, Rhee Y, Lim SK, Lee HC, Lee EJ.

J Endocrinol. 2007 Nov;195(2):255-63.

PMID:
17951536
13.

Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.

Tonetti DA, Rubenstein R, DeLeon M, Zhao H, Pappas SG, Bentrem DJ, Chen B, Constantinou A, Craig Jordan V.

J Steroid Biochem Mol Biol. 2003 Oct;87(1):47-55.

PMID:
14630090
14.

Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.

Lu W, Katzenellenbogen BS.

Horm Cancer. 2017 Aug;8(4):230-242. doi: 10.1007/s12672-017-0298-1. Epub 2017 Jun 2.

15.

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.

Lindberg K, Helguero LA, Omoto Y, Gustafsson JÅ, Haldosén LA.

Breast Cancer Res. 2011 Apr 14;13(2):R43. doi: 10.1186/bcr2865.

16.

Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.

Bao-Lei T, Zhu-Zhong M, Yi S, Jun-Jie Q, Yan D, Hua L, Bin L, Guo-Wei Z, Zhi-Xian S.

J Cell Biochem. 2006 Feb 15;97(3):561-71.

PMID:
16215989
17.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

18.

Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.

Dey P, Ström A, Gustafsson JÅ.

Oncogene. 2014 Aug 14;33(33):4213-25. doi: 10.1038/onc.2013.384. Epub 2013 Sep 30.

PMID:
24077289
19.

Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.

Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.

Steroids. 2013 Nov;78(11):1071-86. doi: 10.1016/j.steroids.2013.07.004. Epub 2013 Jul 26.

PMID:
23891847
20.

Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.

Bozkurt KK, Kapucuoğlu N.

Pathol Res Pract. 2012 Mar 15;208(3):133-9. doi: 10.1016/j.prp.2011.12.015. Epub 2012 Feb 14.

PMID:
22336175

Supplemental Content

Support Center